![Hubert Walinski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hubert Walinski
Directeur/Membre du Conseil chez
CIPHER PHARMACEUTICALS INC.
Fortune : 31 139 $ au 30/06/2026
Profil
Hubert Walinski currently works at Cipher Pharmaceuticals, Inc., as Independent Director from 2023, Portland Holdings, Inc., as Chief Scientific Officer from 2021, and Aic Global Holdings, Inc., as Chief Scientific Officer from 2021.
Dr. Walinski also formerly worked at AstraZeneca Canada, Inc., as Head-Medical Respiratory, Immunology & Vaccines in 2021.
Dr. Walinski received his doctorate degree in 2007 from the University of British Columbia and undergraduate degree in 2001 from McMaster University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/06/2026 | 2 689 ( 0,01 % ) | 31 139 $ | 30/06/2026 |
Postes actifs de Hubert Walinski
| Sociétés | Poste | Début |
|---|---|---|
| CIPHER PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 21/06/2023 |
Aic Global Holdings, Inc.
 Aic Global Holdings, Inc. Aic Global Holdings, Inc. is a privately held investment company headquartered in Portland Holdings. Aic Global Holdings, Inc. owns a diverse portfolio of businesses in various sectors, including media, tourism, and financial services. The company's investment philosophy is focused on enabling Canadian technologies. The company has been involved in the construction of the world's first micro-modular reactor at the Canadian Nuclear Laboratories (CNL). Aic Global Holdings has also collaborated with MBM Holding on healthcare and clean energy sectors of national importance. The company has been appointed to the supervisory board of ITM Isotopen Technologien München AG, a pharmaceutical group of companies. The company is based in Burlington, Canada. The CEO of the company is Joseph Sferrazza. | Directeur Technique/Scientifique/R&D | 01/08/2021 |
Portland Holdings, Inc.
 Portland Holdings, Inc. Financial ConglomeratesFinance Operates as an investment company | Directeur Technique/Scientifique/R&D | 19/11/2021 |
Anciens postes connus de Hubert Walinski
| Sociétés | Poste | Fin |
|---|---|---|
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drug preparations | Directeur Technique/Scientifique/R&D | 01/07/2021 |
Formation de Hubert Walinski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Cipher Pharmaceuticals, Inc.
 Cipher Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Provides laboratory testing and medical imaging services | Health Technology |
Portland Holdings, Inc.
Portland Holdings, Inc. Financial ConglomeratesFinance Operates as an investment company | Finance |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drug preparations | Health Technology |
McMaster University
 McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aic Global Holdings, Inc.
Aic Global Holdings, Inc. Aic Global Holdings, Inc. is a privately held investment company headquartered in Portland Holdings. Aic Global Holdings, Inc. owns a diverse portfolio of businesses in various sectors, including media, tourism, and financial services. The company's investment philosophy is focused on enabling Canadian technologies. The company has been involved in the construction of the world's first micro-modular reactor at the Canadian Nuclear Laboratories (CNL). Aic Global Holdings has also collaborated with MBM Holding on healthcare and clean energy sectors of national importance. The company has been appointed to the supervisory board of ITM Isotopen Technologien München AG, a pharmaceutical group of companies. The company is based in Burlington, Canada. The CEO of the company is Joseph Sferrazza. |
